- Investing Ideas
- Swiss Pharmaceuticals & Biotech Stable Growth Stocks
Swiss Pharmaceuticals & Biotech Stable Growth Stocks
Results
2
0 new
2 companies
Galderma Group
Market Cap: CHF 41.8b
Operates as a dermatology company worldwide.
GALD
CHF 178.25
7D
3.4%
1Y
50.4%
Bachem Holding
Market Cap: CHF 5.4b
Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.
BANB
CHF 71.90
7D
5.8%
1Y
21.9%